3 UAB researchers elected AAAS fellows

December 17, 2009

BIRMINGHAM, Ala. - Three University of Alabama at Birmingham (UAB) professors have been elected fellows of the American Association for the Advancement of Science (AAAS).

Election as a fellow of AAAS is an honor bestowed upon members by their peers. The new fellows from UAB are David Allison, Ph.D., of the Department of Biostatistics; Etty "Tika" Benveniste, Ph.D., of the Department of Cell Biology; and Ruiwen Zhang, M.D., Ph.D., of the Department of Toxicology and Pharmacology.

Benveniste, chair of the Department of Cell Biology and associate director for basic-science research at the UAB Comprehensive Cancer Center, and Zhang, a professor of pharmacology and toxicology and director of the cancer-pharmacology laboratory at UAB, both were selected for their distinguished contributions to their field of study. Allison, director of UAB's Nutrition and Obesity Research Center and a professor in the School of Public Health, was selected for distinguished contributions to his field of study and for outstanding training and mentorship of young scientists.

This year 531 members have been awarded this honor by AAAS because of their scientifically or socially distinguished efforts to advance science or its applications. New fellows are announced in the Dec. 18 issue of the journal Science and will be honored in February at the 2010 AAAS Annual Meeting in San Diego.

Allison runs the biostatistics department's Section on Statistical Genetics. He is a renowned obesity researcher in the fields of quantitative genetics, clinical trials and research methodology. He also is a National Science Foundation-honored professor recognized for his interdisciplinary training and mentoring approach to young investigators interested in statistical methodology, clinical-nutrition research, genomics, obesity, longevity and many other data-driven projects.

Benveniste is a professor of cell biology, physiology and biophysics, neurology and neurobiology. She also is a senior scientist at UAB's Arthritis Center, Center for AIDS Research and the Cancer Center. Her research is focused on immune-system and central-nervous-system inter-communication, discoveries which improve the understanding of autoimmune diseases like multiple sclerosis and AIDS-dementia complex. She is particularly interested in a class of inflammatory and regulatory proteins called cytokines and chemokines present in both the immune and nervous system. Recently, Benveniste has turned her attention to the inflammatory processes that promote brain-cancer growth.

Zhang serves as a senior scientist at UAB's Center for Aging, Center for AIDS Research, Gene Therapy Center and Comprehensive Cancer Center. He was among the first to discover DPD deficiency, an inherited metabolic disorder wherein limited enzyme activity can impact a cancer patient's response to chemotherapy. Zhang also is a leader in studying drugs that work by antisense, which are genetically engineered agents to target the double-stranded structure of DNA for cancer prevention and to deactivate disease-causing genes. Recently, Zhang has been studying a particular gene called MDM2 that helps regulate cancer sensitivity to drug treatment.

The tradition of AAAS fellows began in 1874. Currently, members can be considered for the rank if nominated by the steering groups of the association's 24 sections, or by any three fellows currently AAAS members, or by the AAAS chief executive officer. Each steering group then reviews the nominations of individuals within its respective section and a final list is forwarded to the AAAS Council for a vote.
-end-
About AAAS

The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society, and publisher of the journal Science. AAAS was founded in 1848, and includes some 262 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy; international programs; science education; and more.

About UAB

Known for its innovative and interdisciplinary approach to education at both the graduate and undergraduate levels, the University of Alabama at Birmingham (UAB) is the state of Alabama's largest employer an internationally renowned research university and academic health center whose professional schools and specialty patient care programs are consistently ranked as among the nation's top 50; find more information at www.uab.edu and www.uabmedicine.org.

University of Alabama at Birmingham

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.